NASDAQ:IRON

Disc Medicine Opco (IRON) Stock Forecast, Price & News

$45.69

+6.22 (+15.76%)

(As of 06/9/2023 ET)

Compare

Today's Range: $40.00
▼
$48.60
50-Day Range: $21.19
▼
$45.69
52-Week Range: $11.80
▼
$48.88

Volume: 777,565 shs
Average Volume: 112,516 shs
Market Capitalization: $904.66 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $42.00

Disc Medicine Opco MarketRank™ Forecast

Analyst Rating: Buy
3.00 Rating Score
Upside/Downside: 5.8% Upside
$48.33 Price Target
Short Interest: Healthy
1.54% of Shares Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: 0.85
Based on 21 Articles This Week
Insider Trading: N/A
Proj. Earnings Growth: Decreasing
From ($3.94) to ($4.18) Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.82 out of 5 stars

Medical Sector

630th out of 988 stocks

Pharmaceutical Preparations Industry

297th out of 481 stocks

2.6

Analyst's Opinion

Consensus Rating
Disc Medicine Opco has received a consensus rating of Buy. The company's average rating score is 3.10, and is based on 9 buy ratings, no hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $48.33, Disc Medicine Opco has a forecasted upside of 5.8% from its current price of $45.69.
Amount of Analyst Coverage
Disc Medicine Opco has been the subject of 7 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

3.0

Short Interest

Percentage of Shares Shorted
1.54% of the outstanding shares of Disc Medicine Opco have been sold short.
Short Interest Ratio / Days to Cover
Disc Medicine Opco has a short interest ratio ("days to cover") of 2.8, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month

0.0

Dividend Strength

Dividend Yield
Disc Medicine Opco does not currently pay a dividend.
Dividend Growth
Disc Medicine Opco does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for IRON.

3.3

News and Social Media Coverage

News Sentiment
Disc Medicine Opco has a news sentiment score of 0.85. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.74 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 21 news articles for Disc Medicine Opco this week, compared to 4 articles on an average week.
Search Interest
Only 4 people have searched for IRON on MarketBeat in the last 30 days. This is a decrease of -33% compared to the previous 30 days.
MarketBeat Follows
3 people have added Disc Medicine Opco to their MarketBeat watchlist in the last 30 days. This is an increase of 200% compared to the previous 30 days.

2.5

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Disc Medicine Opco insiders have not sold or bought any company stock.
Percentage Held by Insiders
12.90% of the stock of Disc Medicine Opco is held by insiders. A high percentage of insider ownership can be a sign of company health.
Percentage Held by Institutions
75.42% of the stock of Disc Medicine Opco is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

0.0

Earnings and Valuation

Earnings Growth
Earnings for Disc Medicine Opco are expected to decrease in the coming year, from ($3.94) to ($4.18) per share.
Price to Book Value per Share Ratio
Disc Medicine Opco has a P/B Ratio of 4.50. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About Disc Medicine Opco (NASDAQ:IRON) Stock

Disc Medicine, Inc., a clinical-stage biotechnology company, engages in discovering, developing, and commercializing novel treatments for patients suffering from serious hematologic diseases. It builds a portfolio of therapeutic candidates that address a spectrum of hematologic diseases by targeting fundamental biological pathways of red blood cell biology, primarily heme biosynthesis and iron homeostasis. Disc Medicine, Inc. is based in Watertown, Massachusetts.

Receive IRON Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Disc Medicine Opco and its competitors with MarketBeat's FREE daily newsletter.

IRON Stock News Headlines

June 9, 2023 | finance.yahoo.com

Why Perfectly Rated Disc Medicine, With A 234% Move This Year, Just Put Up Another Big Gain

June 9, 2023 | finance.yahoo.com

Disc Presents Positive Initial Data from Phase 2 BEACON Trial of Bitopertin in Patients with Erythropoietic Protoporphyria (EPP) at European Hematology Association (EHA) 2023 Congress

June 10, 2023 | Behind the Markets (Ad)

"Chilling War Games Show US Forces Crushed" – FOX NEWS

=== BREAKING === "Chilling War Games Show US Forces Crushed" - FOX NEWS After losing to China in repeated war games, U.S. military to spend billions on new "living missile" for armed forces. Investors stand to reap 35,960% on shares of small defense contractor that makes powerful new weapon. Get the name of the stock here >>>

June 8, 2023 | americanbankingnews.com

Analysts Issue Forecasts for Disc Medicine Opco Inc's Q2 2023 Earnings (NASDAQ:IRON)

June 7, 2023 | fool.com

Disc Medicine Opco (NASDAQ: IRON)

June 7, 2023 | americanbankingnews.com

HC Wainwright Begins Coverage on Disc Medicine Opco (NASDAQ:IRON)

June 7, 2023 | americanbankingnews.com

Disc Medicine Opco (NASDAQ:IRON) Sees Strong Trading Volume

June 1, 2023 | finance.yahoo.com

Why Shares of Disc Medicine Opco Climbed This Week

June 10, 2023 | Behind the Markets (Ad)

The single greatest medical breakthrough of all time?

We are on the cusp of a medical breakthrough. And soon, this single breakthrough could lead to the cure of over 6,000 genetic diseases, including Alzheimer's, heart disease, and even cancer! This reminds me of Amgen, where early investors made as much as 46,751% when they released their revolutionary drug to the market.

May 31, 2023 | finance.yahoo.com

Disc Medicine to Participate in the Jefferies Healthcare Conference

May 20, 2023 | americanbankingnews.com

Wedbush Comments on Disc Medicine Opco Inc's Q2 2023 Earnings (NASDAQ:IRON)

May 20, 2023 | americanbankingnews.com

Disc Medicine Opco (NASDAQ:IRON) Now Covered by Raymond James

May 19, 2023 | americanbankingnews.com

Disc Medicine Opco (NASDAQ:IRON) Shares Gap Up to $33.39

May 19, 2023 | msn.com

Raymond James Initiates Coverage of Disc Medicine (IRON) with Outperform Recommendation

May 18, 2023 | americanbankingnews.com

Disc Medicine Opco Inc (NASDAQ:IRON) Receives $37.29 Consensus Target Price from Brokerages

May 17, 2023 | americanbankingnews.com

Disc Medicine Opco (NASDAQ:IRON) Issues Earnings Results, Misses Estimates By $0.53 EPS

May 17, 2023 | americanbankingnews.com

Q2 2023 EPS Estimates for Disc Medicine Opco Inc (NASDAQ:IRON) Boosted by SVB Leerink

May 15, 2023 | finance.yahoo.com

Disc Medicine Reports First Quarter 2023 Financial Results and Provides Business Update

May 11, 2023 | finance.yahoo.com

Disc Medicine Announces Presentation of Initial Data from Phase 2 BEACON Trial in Patients with Erythropoietic Protoporphyria (EPP) at European Hematology Association (EHA) 2023 Congress

May 10, 2023 | finance.yahoo.com

Is a Surprise Coming for Disc Medicine (IRON) This Earnings Season?

May 5, 2023 | finance.yahoo.com

Disc Medicine, Inc. (IRON) is on the Move, Here's Why the Trend Could be Sustainable

May 4, 2023 | finance.yahoo.com

Disc Medicine, Inc. (IRON) Is Up 4.40% in One Week: What You Should Know

May 3, 2023 | americanbankingnews.com

Disc Medicine Opco (NASDAQ:IRON) Trading Up 4.4%

April 29, 2023 | americanbankingnews.com

Disc Medicine Opco (NASDAQ:IRON) Now Covered by Analysts at Cantor Fitzgerald

April 29, 2023 | americanbankingnews.com

Wedbush Weighs in on Disc Medicine Opco Inc's FY2026 Earnings (NASDAQ:IRON)

April 28, 2023 | americanbankingnews.com

Q1 2023 EPS Estimates for Disc Medicine Opco Inc (NASDAQ:IRON) Boosted by SVB Leerink

April 28, 2023 | americanbankingnews.com

Analysts Offer Predictions for Disc Medicine Opco Inc's Q1 2023 Earnings (NASDAQ:IRON)

See More Headlines

IRON Price History

30 days | 90 days | 365 days | Advanced Chart

IRON Company Calendar

Last Earnings: 5/15/2023
Today: 6/10/2023
Next Earnings (Estimated): 8/10/2023
Fiscal Year End: 12/31/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceutical preparations
Sub-Industry: N/A
Sector: Medical
Current Symbol: NASDAQ:IRON
CUSIP: N/A
CIK: 1816736
Web: www.discmedicine.com
Phone: 617-401-4400
Fax: N/A
Employees: N/A
Year Founded: N/A

Price Target and Rating

Average Stock Price Forecast: $48.33
High Stock Price Forecast: $75.00
Low Stock Price Forecast: $30.00
Forecasted Upside/Downside: -8.1%
Consensus Rating: Buy
Rating Score (0-4): 3.00
Research Coverage: 10 Analysts

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-46,830,000.00
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: -38.49%
Return on Assets: -36.03%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 24.26
Quick Ratio: 24.26

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $10.15 per share
Price / Book: 4.50

Miscellaneous

Outstanding Shares: 19,800,000
Free Float: 17,245,000
Market Cap: $904.66 million
Optionable: Not Optionable
Beta: -0.22

Key Executives

Dr. Donald William Nicholson Ph.D. (Age 65)
Exec. Chairman

Dr. John D. Quisel Esq. (Age 52)
J.D., Ph.D., CEO, Pres, Sec. & Director

Dr. Brian MacDonald ChB
MB, Ph.D., Co-Founder & Chief Innovation Officer

Ms. Joanne Bryce C.P.A.
CFO, Principal Financial & Accounting Officer and Treasurer

Dr. Rahul Khara J.D.
Pharm.D., Gen. Counsel

Mr. Jonathan Yu
Chief Bus. Officer

Mr. William Savage M.D.
Ph.D., Chief Medical Officer

Mr. Srikanth Venkatraman Ph.D.
Sr. VP & Head of Chemistry

Key Competitors

View All Competitors

Institutional Ownership

View All Institutional Transactions

IRON Stock - Frequently Asked Questions

Should I buy or sell Disc Medicine Opco stock right now?: 10 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Disc Medicine Opco in the last twelve months. There are currently 9 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" IRON shares.
View IRON analyst ratings or view top-rated stocks.
What is Disc Medicine Opco's stock price forecast for 2023?: 10 brokerages have issued 12 month price objectives for Disc Medicine Opco's shares. Their IRON share price forecasts range from $30.00 to $75.00. On average, they expect the company's share price to reach $48.33 in the next year. This suggests a possible upside of 5.8% from the stock's current price.
View analysts price targets for IRON or view top-rated stocks among Wall Street analysts.
How have IRON shares performed in 2023?: Disc Medicine Opco's stock was trading at $17.95 at the start of the year. Since then, IRON stock has increased by 154.5% and is now trading at $45.69.
View the best growth stocks for 2023 here.
When is Disc Medicine Opco's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Thursday, August 10th 2023.
View our IRON earnings forecast.
How were Disc Medicine Opco's earnings last quarter?: Disc Medicine Opco Inc (NASDAQ:IRON) announced its earnings results on Monday, May, 15th. The company reported ($1.20) EPS for the quarter, missing analysts' consensus estimates of ($0.67) by $0.53.

What is Disc Medicine Opco's stock symbol?: Disc Medicine Opco trades on the NASDAQ under the ticker symbol "IRON."
Who are Disc Medicine Opco's major shareholders?: Disc Medicine Opco's stock is owned by many different institutional and retail investors. Top institutional shareholders include Bain Capital Life Sciences Investors LLC (10.48%), Logos Global Management LP (2.76%), Sphera Funds Management LTD. (1.16%), BML Capital Management LLC (1.10%), FMR LLC (0.80%) and Ghost Tree Capital LLC (0.53%).
How do I buy shares of Disc Medicine Opco?: Shares of IRON stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Disc Medicine Opco's stock price today?: One share of IRON stock can currently be purchased for approximately $45.69.
How much money does Disc Medicine Opco make?: Disc Medicine Opco (NASDAQ:IRON) has a market capitalization of $904.66 million.
How can I contact Disc Medicine Opco?: Disc Medicine Opco's mailing address is 297 Boston Post Road #248, Wayland MA, 01778. The official website for the company is www.discmedicine.com. The company can be reached via phone at 617-401-4400 or via email at ir@geminitherapeutics.com.

This page (NASDAQ:IRON) was last updated on 6/10/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial